Y Intercept Hong Kong Ltd Makes New $5.02 Million Investment in Oscar Health, Inc. $OSCR

Y Intercept Hong Kong Ltd acquired a new position in shares of Oscar Health, Inc. (NYSE:OSCR) in the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 234,153 shares of the company’s stock, valued at approximately $5,020,000. Y Intercept Hong Kong Ltd owned 0.09% of Oscar Health at the end of the most recent quarter.

Other institutional investors have also recently bought and sold shares of the company. Envestnet Asset Management Inc. lifted its holdings in shares of Oscar Health by 200.9% during the 2nd quarter. Envestnet Asset Management Inc. now owns 30,210 shares of the company’s stock valued at $648,000 after buying an additional 20,171 shares during the last quarter. Lane Generational LLC acquired a new stake in shares of Oscar Health during the 2nd quarter valued at about $4,800,000. Nisa Investment Advisors LLC lifted its holdings in shares of Oscar Health by 71.4% during the 2nd quarter. Nisa Investment Advisors LLC now owns 2,658 shares of the company’s stock valued at $57,000 after buying an additional 1,107 shares during the last quarter. Wealthfront Advisers LLC acquired a new stake in shares of Oscar Health during the 2nd quarter valued at about $940,000. Finally, Caitong International Asset Management Co. Ltd lifted its holdings in shares of Oscar Health by 385.9% during the 2nd quarter. Caitong International Asset Management Co. Ltd now owns 16,731 shares of the company’s stock valued at $359,000 after buying an additional 13,288 shares during the last quarter. 75.70% of the stock is currently owned by institutional investors and hedge funds.

Oscar Health Stock Performance

Shares of NYSE OSCR opened at $19.58 on Wednesday. The company has a quick ratio of 0.86, a current ratio of 0.86 and a debt-to-equity ratio of 0.26. The business’s 50 day moving average is $18.99 and its two-hundred day moving average is $16.51. The company has a market cap of $5.06 billion, a P/E ratio of -24.17 and a beta of 1.89. Oscar Health, Inc. has a 12 month low of $11.20 and a 12 month high of $23.80.

Oscar Health (NYSE:OSCR) last issued its quarterly earnings results on Wednesday, August 6th. The company reported ($0.89) EPS for the quarter, topping the consensus estimate of ($0.90) by $0.01. The company had revenue of $2.86 billion for the quarter, compared to the consensus estimate of $2.88 billion. Oscar Health had a negative return on equity of 13.78% and a negative net margin of 1.50%.The company’s revenue for the quarter was up 29.0% on a year-over-year basis. During the same period in the previous year, the business posted $0.20 EPS. On average, equities analysts expect that Oscar Health, Inc. will post 0.69 EPS for the current year.

Analyst Upgrades and Downgrades

Several brokerages have recently issued reports on OSCR. Baird R W lowered Oscar Health from a “strong-buy” rating to a “hold” rating in a report on Friday, July 25th. Wall Street Zen lowered Oscar Health from a “hold” rating to a “sell” rating in a report on Saturday, August 9th. Zacks Research upgraded Oscar Health from a “strong sell” rating to a “hold” rating in a report on Monday, October 13th. Robert W. Baird reiterated a “neutral” rating and set a $14.00 price target (down from $28.00) on shares of Oscar Health in a report on Friday, July 25th. Finally, Piper Sandler cut their price objective on Oscar Health from $14.00 to $13.00 and set a “neutral” rating on the stock in a research note on Thursday, August 14th. Six equities research analysts have rated the stock with a Hold rating and six have given a Sell rating to the company. According to MarketBeat.com, the stock presently has an average rating of “Reduce” and an average price target of $13.19.

Insider Buying and Selling

In other Oscar Health news, insider Mario Schlosser sold 395,000 shares of Oscar Health stock in a transaction that occurred on Monday, September 22nd. The stock was sold at an average price of $18.43, for a total value of $7,279,850.00. Following the transaction, the insider directly owned 501,148 shares of the company’s stock, valued at $9,236,157.64. The trade was a 44.08% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. 25.11% of the stock is currently owned by corporate insiders.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.